Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

1718 Press Releases
DateTitleCompany
22 Jul 15 European Commission Approves Merck’s Anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma Merck,
Published by
PharmiWeb.com
22 Jul 15 Biogen Presents New Data from Phase 1B Study of Investigational Alzheimer’s Disease Treatment Aducanumab (BIIB037) at Alzheimer’s Association International Conference® 2015 Biogen,
Published by
PharmiWeb.com
22 Jul 15 World Brain Day puts spotlight on epilepsy UCB,
Published by
PharmiWeb.com
22 Jul 15 Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease Eli Lilly,
Published by
PharmiWeb.com
22 Jul 15 Resistance to cancer drug found to occur naturally in the breast The Institute of Cancer Research,
Published by
PharmiWeb.com
22 Jul 15 AstraZeneca provides update on selumetinib in uveal melanoma AstraZeneca,
Published by
PharmiWeb.com
22 Jul 15 Roche Diagnostics strengthens its blood screening portfolio with an assay to identify Human T-lymphotropic virus I/II (HTLV-I/II) infection to increase blood safety Roche Diagnostics,
Published by
PharmiWeb.com
22 Jul 15 Cell therapy using human iPSC - derived renal progenitors ameliorates acute kidney injury in mice” published in “Stem Cells Translational Medicine” on line Astellas,
Published by
PharmiWeb.com
22 Jul 15 Merck Announces Fourth-Quarter 2015 Dividend Merck,
Published by
PharmiWeb.com
22 Jul 15 Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility Pfizer,
Published by
PharmiWeb.com
22 Jul 15 New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated for Cognitive Decline Lilly,
Published by
PharmiWeb.com
22 Jul 15 Vyvanse® (lisdexamfetamine dimesylate) Positive Top-Line Results in Maintenance of Efficacy Study in Adults with Moderate to Severe Binge Eating Disorder Abbott,
Published by
PharmiWeb.com
22 Jul 15 Abbott Reports Second-Quarter 2015 Results Abbott,
Published by
PharmiWeb.com
22 Jul 15 Regular consumption of sugary drinks associated with type 2 diabetes Medical Research Council (MRC),
Published by
PharmiWeb.com
22 Jul 15 ABLYNX SIGNIFICANTLY EXPANDS ITS IMMUNO-ONCOLOGY COLLABORATION WITH MERCK & CO., INC. ABLYNX,
Published by
PharmiWeb.com
22 Jul 15 GILEAD ANNOUNCES PHASE 3 RESULTS FROM THE FIRST STUDY TO EVALUATE SWITCHING FROM TDF-BASED REGIMENS TO A TAF-BASED REGIMEN CONTAINING Elvitegravir, Cobicistat, EMTRICITABINE and Tenofovir Alafenamide (E/C/F/TAF)[i] Johnson & Johnson,
Published by
PharmiWeb.com
22 Jul 15 Johnson & Johnson to Challenge Novartis in Axial Spondyloarthrtis Treatment Space, says GlobalData Johnson & Johnson,
Published by
PharmiWeb.com
22 Jul 15 Gilead Sciences to Release Second Quarter 2015 Financial Results on Tuesday, July 28, 2015 Gilead Sciences,
Published by
PharmiWeb.com
22 Jul 15 Ensuring biomedical research is gold standard – through better use of chemical probes The Institute of Cancer Research,
Published by
PharmiWeb.com
22 Jul 15 New ‘TripAdvisor’ site to address use of substandard biomedical research tools The Institute of Cancer Research,
Published by
PharmiWeb.com
22 Jul 15 Second-Generation Investigational HIV-1 Maturation Inhibitor Demonstrates Positive New Phase IIa Results, Supporting Continued Development Bristol-Myers Squibb,
Published by
PharmiWeb.com
22 Jul 15 Gilead Announces Phase 3 Results From the First Study to Evaluate Switching From TDF-Based Regimens to a TAF-Based Regimen Containing Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide (E/C/F/TAF) Gilead,
Published by
PharmiWeb.com
22 Jul 15 ABPI responds to NHS England's proposals for the Cancer Drugs Fund ABPI,
Published by
PharmiWeb.com
22 Jul 15 MHRA can place UK at the forefront of a global drive to improve public health according to Triennial Review. MHRA,
Published by
PharmiWeb.com
22 Jul 15 Alimera Sciences Signs Knight Therapeutics As Exclusive ILUVIEN® Distributor For Canada Alimera Sciences,
Published by
PharmiWeb.com
22 Jul 15 Talentmark Welcomes Andreas Reimer Talentmark,
Published by
PharmiWeb.com
22 Jul 15 Lysogene and Alcyone Lifesciences enter into a collaboration for mucopolysaccharidosis type IIIA (MPS IIIA) Alcyone Lifesciences,
Published by
PharmiWeb.com
22 Jul 15 Intercept Pharmaceuticals Appoints Richard Kim as Senior Vice President, Commercial Head of U.S. Intercept Pharmaceuticals,
Published by
PharmiWeb.com
22 Jul 15 Technical Roundup on Drugs - Generic Equities Allergan, Akorn, Ironwood Pharma, Pacira Pharma, and Catalent Equity Research Institute,
Published by
PharmiWeb.com
22 Jul 15 Recro Pharma Appoints Scott Rizzo as General Manager Recro Pharma,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.